1. Home
  2. LOAN vs AADI Comparison

LOAN vs AADI Comparison

Compare LOAN & AADI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LOAN
  • AADI
  • Stock Information
  • Founded
  • LOAN 1989
  • AADI 2011
  • Country
  • LOAN United States
  • AADI United States
  • Employees
  • LOAN N/A
  • AADI N/A
  • Industry
  • LOAN Real Estate Investment Trusts
  • AADI Biotechnology: Pharmaceutical Preparations
  • Sector
  • LOAN Real Estate
  • AADI Health Care
  • Exchange
  • LOAN Nasdaq
  • AADI Nasdaq
  • Market Cap
  • LOAN 65.8M
  • AADI 77.5M
  • IPO Year
  • LOAN 1999
  • AADI N/A
  • Fundamental
  • Price
  • LOAN $5.75
  • AADI $2.79
  • Analyst Decision
  • LOAN
  • AADI Hold
  • Analyst Count
  • LOAN 0
  • AADI 3
  • Target Price
  • LOAN N/A
  • AADI $1.75
  • AVG Volume (30 Days)
  • LOAN 10.2K
  • AADI 114.1K
  • Earning Date
  • LOAN 03-10-2025
  • AADI 03-12-2025
  • Dividend Yield
  • LOAN 8.00%
  • AADI N/A
  • EPS Growth
  • LOAN 6.53
  • AADI N/A
  • EPS
  • LOAN 0.49
  • AADI N/A
  • Revenue
  • LOAN $7,394,068.00
  • AADI $25,070,000.00
  • Revenue This Year
  • LOAN N/A
  • AADI $8.43
  • Revenue Next Year
  • LOAN N/A
  • AADI $5.41
  • P/E Ratio
  • LOAN $11.73
  • AADI N/A
  • Revenue Growth
  • LOAN 5.79
  • AADI 7.80
  • 52 Week Low
  • LOAN $4.60
  • AADI $1.21
  • 52 Week High
  • LOAN $5.90
  • AADI $3.81
  • Technical
  • Relative Strength Index (RSI)
  • LOAN 59.17
  • AADI 48.57
  • Support Level
  • LOAN $5.55
  • AADI $2.56
  • Resistance Level
  • LOAN $5.82
  • AADI $2.94
  • Average True Range (ATR)
  • LOAN 0.09
  • AADI 0.13
  • MACD
  • LOAN 0.00
  • AADI 0.01
  • Stochastic Oscillator
  • LOAN 79.41
  • AADI 57.50

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

About AADI Aadi Bioscience Inc.

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

Share on Social Networks: